Rajiv Sarin

Specialty: Radiation Oncology - Thyroid & cancer genomics

Location: Global

Tier: ELITE

H-Index: 110

Years Active: 0

Hospital Affiliations

• ACTREC - Faculty

Key Publications

1. "Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial." - Lancet Oncol (2024)
2. "Heritable defects in telomere and mitotic function selectively predispose to sarcomas." - Science (2023)
3. "War games and cancer." - J Cancer Res Ther (2005)
4. "Ethics and clinical utility of direct-to-consumer genetic tests." - J Cancer Res Ther (2015)
5. "Tata Memorial Centre Evidence Based Management of Breast cancer." - Indian J Cancer (2024)

Knowledge Graph Relationships

Rajiv Sarin is a Radiation Oncology - Thyroid & cancer genomics specialist affiliated with ACTREC. Authored 5 scholarly articles.